ArticleProtoplasma2026
Ultrasound-assisted aqueous extract of Campanula macrostachya enhances fibroblast repair via antioxidant and cytokine-modulatory mechanisms.
Article in Protoplasma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plants are valuable sources of bioactive metabolites that influence cellular physiology and tissue repair. This study investigates the phytochemical composition and cellular wound-healing potential of the aqueous extract of Campanula macrostachya Boiss. (Campanulaceae), an endemic Anatolian species traditionally used for treating skin injuries. The extract was obtained via ultrasound-assisted extraction and characterized by LC–MS, revealing chlorogenic and caffeic acids as the dominant phenolics. Antioxidant properties were evaluated using DPPH, ABTS, FRAP, CUPRAC, phosphomolybdenum, and ferrous ion chelating assays, while enzyme inhibition screening included acetylcholinesterase, butyrylcholinesterase, tyrosinase, α-amylase, and α-glucosidase inhibitory activities. In human dermal fibroblast (HDFa) cultures, the extract exhibited no cytotoxicity up to 62.5 µg/mL, significantly enhanced cell viability, and promoted 98% wound closure within 48 h in scratch assays. Moreover, TNF-α and IL-1β levels were downregulated, suggesting an anti-inflammatory contribution to tissue repair. These findings provide mechanistic insights into the cellular basis of C. macrostachya’s ethnopharmacological use and support its potential as a source of phenolic compounds that modulate redox balance and cytokine activity. The study highlights the relevance of plant-derived antioxidants in regulating fibroblast behavior and suggests their potential for future development of natural agents for skin-related applications, based on in vitro findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.